Articles
Getting personal with cancer
Recent work on developing targeted treatments for pancreatic cancer is paving the way for new approaches in personalised medicine. [ + ]
Biotech survey shows advanced manufacturing heading overseas
The annual Biotechnology Industry Position Survey (2014) shows a worrying trend: advanced manufacturing associated with this industry of the future is following traditional manufacturing and there has been a sharp increase in the number of companies heading overseas. [ + ]
Atomo wins Best In Show at MDEA
Atomo Diagnostics' HIV blood test, AtomoRapid HIV, has been named Best In Show at the Medical Design Excellence Awards. [ + ]
Eucalyptus genome successfully sequenced
The genetic blueprint of the Eucalyptus grandis (flooded gum) has been sequenced for the first time. The five-year effort to analyse the 640 million base-pair genome was conducted by 80 researchers from 30 institutions across 18 countries. [ + ]
Playing chicken with Campylobacter
Potentially deadly pathogenic strains of Salmonella and Escherichia coli get most of the headlines, but Professor Gary Dykes says most cases of non-lethal food poisoning in Australia are due to diners running afoul of poorly cooked chicken, and its microbial hanger-on, Campylobacter. [ + ]
UWA Professor named WA's Chief Scientist
Medical research luminary Professor Peter Klinken has taken the role of Western Australia's Chief Scientist and aims to change the state's research focus from oil and gas mining to biotechnology. [ + ]
Controlling controlled and sterile environments
Automated environmental monitoring and biological monitoring systems provide effective and reliable methods for monitoring of viable and non-viable particles in Grade A/B cleanrooms along with other critical environmental conditions such as pressure, relative humidity and temperature. [ + ]
Viralytics presents more strong Cavatak trial data
Viralytics (ASX:VLA) announced that Cavatak has to date generated an overall response rate of 26% during a phase II melanoma trial and has demonstrated synergy with mAb therapy during preclinical research. [ + ]
A micro diffractometer for minerals research
Scientific instrument company AXT has won the bid to supply the Mawson Institute at the University of South Australia with a Rigaku D/Max Rapid II Dual Wavelength Micro X-Ray Diffractometer - claimed to be most advanced lab-based micro diffractometer in the country. [ + ]
Survival secrets of Deep Lake
Potentially deadly pathogenic strains of Salmonella and Escherichia coli get most of the headlines, but Professor Gary Dykes says most cases of non-lethal food poisoning in Australia are due to diners running afoul of poorly cooked chicken, and its microbial hanger-on, Campylobacter. [ + ]
World's most sensitive thermometer created
Researchers from the Institute for Photonics and Advanced Sensing have produced what is claimed to be the world's most sensitive thermometer. The new and unorthodox method uses light to measure temperature. [ + ]
Cochlear to launch new implant in EU in June
Cochlear (ASX:COH) will this month launch the first in its Nucleus Profile line of implants - the successor to its Cl500 series - in Europe. [ + ]
Benitec treats first patient in HCV trial
Benitec Biopharma (ASX:BLT) has commenced a phase I/IIa trial of ddRNAi-based therapeutic TT-034, marking the first time the treatment candidate has been used in humans. [ + ]
Australia rises to the challenge of creating synthetic yeast
Australia has joined the Yeast 2.0 project, an international effort to create the world's first ever synthetic complex organism: a particular strain of yeast. [ + ]
Sienna reagent and cancer biomarker registered with FDA
The US FDA has registered the lead product of Melbourne-based biotech company Sienna Cancer Diagnostics - the antibody SCD-A7.
[ + ]
